InflaRx
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.About IFRX
InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab.
IFRX Key Statistics
Stock Snapshot
As of today, InflaRx(IFRX) shares are valued at $1.82. The company's market cap stands at 267.34M, with a P/E ratio of -1.74.
On 2026-07-21, InflaRx(IFRX) stock moved within a range of $1.81 to $2.07. With shares now at $1.82, the stock is trading +0.6% above its intraday low and -12.1% below the session's peak.
Trading activity shows a volume of 882.9K, compared to an average daily volume of 1.05M.
The stock's 52-week range extends from a low of $0.74 to a high of $2.95.
The stock's 52-week range extends from a low of $0.74 to a high of $2.95.
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.